Impax Asset Management Group plc grew its stake in Enfusion, Inc. (NYSE:ENFN – Free Report) by 25.4% during the 3rd quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 676,948 shares of the company’s stock after acquiring an additional 136,948 shares during the quarter. Impax Asset Management Group plc’s holdings in Enfusion were worth $6,424,000 at the end of the most recent quarter.
Other hedge funds have also added to or reduced their stakes in the company. Allspring Global Investments Holdings LLC bought a new position in shares of Enfusion during the first quarter valued at $44,000. RiverPark Advisors LLC bought a new position in shares of Enfusion during the second quarter valued at $68,000. Arizona State Retirement System bought a new position in shares of Enfusion during the second quarter valued at $86,000. Price T Rowe Associates Inc. MD bought a new position in shares of Enfusion during the first quarter valued at $102,000. Finally, Quadrature Capital Ltd bought a new position in shares of Enfusion during the first quarter valued at $109,000. 81.05% of the stock is owned by institutional investors.
Enfusion Price Performance
Shares of NYSE:ENFN opened at $9.79 on Friday. The company has a market cap of $1.26 billion, a P/E ratio of 244.75, a PEG ratio of 3.62 and a beta of 0.93. Enfusion, Inc. has a 1 year low of $7.52 and a 1 year high of $10.45. The stock’s fifty day moving average price is $8.97 and its 200-day moving average price is $8.86.
Enfusion Profile
Enfusion, Inc provides software-as-a-service solutions for investment management industry in the United States, Europe, the Middle East, Africa, and the Asia Pacific. The company provides Portfolio Management System, which generates a real-time investment book of record that consists of valuation and risk tools, which allows users to analyze aggregated or decomposed portfolio data for chief investment officers (CIOs) and portfolio managers; and Order and Execution Management System that enables portfolio managers, traders, compliance teams, and analysts to electronically communicate trade orders for a variety of asset classes, manage trade orders, and systemically enforce trading regulations and internal guidelines.
See Also
- Five stocks we like better than Enfusion
- How to Buy Cheap Stocks Step by Step
- How Whitestone REIT Is Transforming Sun Belt Retail Growth
- The Basics of Support and Resistance
- Top-Performing Non-Leveraged ETFs This Year
- Stock Ratings and Recommendations: Understanding Analyst Ratings
- Rivian’s Wild Ride: Is the Dip a Buying Opportunity?
Want to see what other hedge funds are holding ENFN? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Enfusion, Inc. (NYSE:ENFN – Free Report).
Receive News & Ratings for Enfusion Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Enfusion and related companies with MarketBeat.com's FREE daily email newsletter.